AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MAPS

Share Issue/Capital Change Jul 28, 2021

4072_tar_2021-07-28_3adf4d92-4931-4b11-9c33-768b35048419.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Informazione
Regolamentata n.
20153-39-2021
Data/Ora Ricezione
28 Luglio 2021
09:28:47
AIM -Italia/Mercato
Alternativo del Capitale
Societa' : MAPS
Identificativo
Informazione
Regolamentata
: 150367
Nome utilizzatore : MAPSN03 - Ciscato
Tipologia : REGEM; 3.1
Data/Ora Ricezione : 28 Luglio 2021 09:28:47
Data/Ora Inizio
Diffusione presunta
: 28 Luglio 2021 09:28:48
Oggetto : ACQUISITION OF THE REMAINING
7.94% OF THE SHARE CAPITAL OF
MAPS HEALTHCARE, FOLLOWING THE
POSITIVE CONCLUSION OF THE BOARD
OF DIRECTORS' VERIFICATIONS
Testo del comunicato

Vedi allegato.

MAPS: ACQUISITION OF THE REMAINING 7.94% OF THE SHARE CAPITAL OF MAPS HEALTHCARE, FOLLOWING THE POSITIVE CONCLUSION OF THE BOARD OF DIRECTORS' VERIFICATIONS

Parma, 28 July 2021

MAPS S.p.A. (MAPS:IM; IT0005364333), an Innovative SME listed on AIM Italy and active in the digital transformation sector (the "Company"), following up on what was communicated on 11 July 2021 and 19 July 2021, with reference to the acquisition of the residual stake equal to 7.94% of the share capital of Maps Healthcare S.r.l. (respectively, the "Comprehensive Shareholding" and "MH") by Fabrizio Biotti and Mauro Max Di Maulo, and, in particular, to the contribution of the portion of the Comprehensive Shareholding itself, equal to 4.411% of the share capital of MH (the "Contribution Shareholding"), hereby informs that, the Board of Directors of the Company, meeting on 26th July, has carried out the verifications pursuant to art. 2343-quater of the Italian Civil Code and has ascertained that in the period subsequent to the reference date of the valuations prepared by the independent expert Dr. Roberto Medici (the "Expert"), i.e. 31 May 2021, no "significant new events" have occurred that would significantly change the value of the Contribution Shareholding.

The Board also verified the professionalism and independence requirements of the Expert who carried out the evaluations pursuant to Article 2343-ter, paragraph 2, letter b) of the Italian Civil Code and Article 2440 of the Italian Civil Code.

As a result of the contribution of the Contribution Participation and the above-specified verifications, 172,018 ordinary shares (the "Shares")will be issued, having the same ISIN Code as those outstanding.

The Company will issue the Shares following the filing of the declaration pursuant to Article 2343 quater of the Italian Civil Code.

Following the issue of the Shares, the Company's share capital will amount to Euro 1,265,214.46 comprising 10,687,741 ordinary shares, with no par value.

MAPS GROUP

Release available on and on www.mapsgroup.it

Founded in 2002, MAPS is an Innovative SME operating in the digital transformation sector. With its registered office in Parma and with approximately 200 employees, it produces and distributes software for the analysis of big data that allows client companies to manage and analyse large quantities of data and information, helping them make strategic and operational decisions and define new business models. It operates in a context characterised by high growth potential: the global market for digital transformation technologies reached \$1,100 billion in 2018; in 2020, a market of \$1,600 billion is estimated (CAGR 2018-2020 approximately +20%). MAPS operates through 3 business units (Large Enterprise, Healthcare Industry, Gzoom) and has a portfolio of over 220 highly loyal Customers from different markets: Telco, Utilities, Healthcare, Retail, Industry and Public Administration.

Through the Patient Journey line of products, it is a leader in the sector of patient reception in healthcare facilities, presiding over the market with over 1,300 installations, which manage the access paths of over 20 million patients nationwide. The Group invests constantly in R&D. The Research & Solutions division, established in 2016, is responsible for identifying market needs and developing software solutions.

The Group closed 2020 with consolidated revenues of Euro 17.9 million and an EBITDA of Euro 3.4 million. In the last 3 years, MAPS has tripled revenue from proprietary solutions and more than doubled EBITDA. The company is characterised by high levels of recurring revenues: recurring fee revenues represent 28% of consolidated operating revenues in 2020. The Group's organic growth has been accompanied by a significant M&A activity, with the acquisition of IG Consulting (2011), Artexe (2018), Roialty (2019) and SCS Computers (2020).

CONTACTS

MAPS T +390521052300 [email protected]

Marco Ciscato – Investor Relations Manager [email protected]

NOMAD BPER Banca | T +390272 74 92 29 [email protected]

INVESTOR RELATIONS & FINANCIAL MEDIA IR Top Consulting | T +390245473884 Maria Antonietta Pireddu, [email protected] │ Federico Nasta, [email protected] Domenico Gentile, [email protected] │ Antonio Buozzi, [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.